Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity
Title:
Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity
Author:
Segota, Ena Mekhail, Tarek Olencki, Thomas Hutson, Thomas E. Dreicer, Robert Wacker, Brenda Osterwalder, Bruno Elson, Paul Zhou, Ming Bukowski, Ronald M.